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Abstract
Background: A high saturated fat (SFA) intake may stimulate progression of atherosclerosis, and may be positively associated
with expression of adhesion molecules. Methods: In moderately hypercholesterolaemic participants of a dietary intervention study
(n=103; 5510 years), we examined associations between reported changes in SFA intake and changes in carotid and femoral
intima-media thickness (IMT) and soluble intercellular adhesion molecule-1 (sICAM-1) levels after 2 years. The carotid and
femoral IMT was assessed by high-resolution B-mode ultrasound images. Results: After 2 years, dietary intake of SFA decreased
with 1.82.6% of energy (P0.01). In the lowest quintile of change in SFA intake (−5.91.4% of energy), changes in carotid
and femoral IMT were +0.03 mm (SEM 0.03) and −0.09 mm (SEM 0.07), respectively, versus +0.10 mm (SEM 0.03), +0.17
mm (SEM 0.07) in the top quintile (+1.60.7% of energy) (P linear trend 0.07 (carotis), 0.02 (femoralis)). Changes in sICAM-1
were −19.0 ng/nl (SEM 5.6) in the lowest quintile, versus +8.6 ng/ml (SEM 5.3) in the top quintile (P linear trend 0.001),
adjusted for baseline level, SFA intake, body mass index, age, changes in intake of fruit, polyunsaturated fat, and dietary
cholesterol. Adjustments for changes in established risk factors did not alter these results. Conclusions: Decreased SFA intake may
reduce progression of atherosclerosis, as assessed by IMT, and is associated with reduced levels of sICAM-1 after 2 years. Further
research using randomised placebo-controlled trials is necessary to exclude potential confounding variables and to confirm
causality. © 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
There is convincing evidence that the intake of satu-
rated fatty acids (SFA) is associated with increased
coronary artery disease incidence and mortality [1,2]. A
diet low in total fat and SFA has been shown to retard
the overall progression of coronary artery disease [3],
but the impact on progression of peripheral atheroscle-
rosis is less well known. The mechanisms by which a
decrease in SFA intake may retard atherosclerotic pro-
gression include lowering of the concentration of total
and LDL cholesterol [4]. Furthermore, recent research
showed that fatty acids influence the expression of
intercellular and vascular adhesion molecules in vitro
[5,6]. The level of soluble intercellular adhesion
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molecule-1 (sICAM-1) has been independently associ-
ated with risk of myocardial infarction [7]. Further, the
adhesion molecules play a crucial role in the attachment
of leucocytes to the endothelium [8], which may be an
initial phase in the atherosclerotic process. An inverse
association has been shown between the number of
double bonds of the fatty acids and the expression of
the adhesion molecules [6]. Hence, it is expected that
the dietary substitution of SFA (no double bonds) with
polyunsaturated fatty acids (more than one double
bond) decreases the expression of adhesion molecules.
The extent of (subclinical) atherosclerosis can be
estimated by the intima-media thickness (IMT) of
larger arteries, which is associated with the develop-
ment of cardiovascular symptoms [9]. A cross-sectional
study observed a positive association between SFA
content of the cholesteryl ester and carotid IMT, inde-
pendent of LDL and HDL cholesterol [10]. However,
longitudinal data that assess the impact of changes in
dietary SFA intake on IMT are limited. Within the
context of a dietary intervention project, among sub-
jects with elevated risk at developing cardiovascular
diseases, we investigated associations between reported
changes in SFA intake and changes in carotid and
femoral IMT after 2 years of follow-up. Furthermore,
we measured sICAM-1 levels as a marker of expression
of ICAM-1 on different cells that play a pathophysio-
logical role in atherosclerosis, such as endothelial cells,
macrophages, T cells, and smooth muscle cells [11].
2. Methods
2.1. Study design
This study was part of a dietary prevention project
for high-risk groups in The Netherlands, the so-called
MARGARIN study. The design of the MARGARIN
study is described in extensu elsewhere [12]. The present
study includes the subjects from the intervention group
since the IMT was assessed only in this group (38 men,
65 women; 5510 years). The intervention group re-
ceived nutritional education in groups, and specific
nutritional guidelines consisted of a daily intake of 5–7
slices of bread, 400 g of vegetables, 2 pieces of fruit,
2–3 lean dairy products, 0–2 consumptions of alcohol
(if already a regular consumer), fish at dinner twice a
week, less red meat, less fat cheese, and fewer eggs.
Furthermore, the intervention group received mar-
garine with a high content of polyunsaturated fat (com-
position: 60% PUFA; 20% SFA) that could be used ad
libitum for 2 years. The study design was approved by
the medical ethical committee of the Groningen Univer-
sity Hospital, and written informed consent was ob-
tained from each participant.
2.2. Participants
Eligible subjects were 30–70 years old, had a serum
total cholesterol concentration between 6.0 and 8.0
mmol/l (mean of two separate measurements) and at
least two of the following cardiovascular risk factors:
high blood pressure (diastolic 95 mmHg and/or sys-
tolic 160 mmHg) or use of anti-hypertensive medica-
tion, body mass index 27 kg/m2, smoking, history of
cardiovascular disease or a family history of onset of
cardiovascular disease before the age of 60. The exclu-
sion criteria were diabetes mellitus, hypothyroidism,
and use of acetylsalicylic acid, anti-coagulants, or
cholesterol lowering drugs.
2.3. Measurements
A standardised questionnaire was used to establish
smoking habits and the presence of a family history of
cardiovascular disease. Body weight was measured
without shoes and heavy clothing. Sitting blood pres-
sure was measured after rest by automatic device (Di-
namap; Critikon Inc.,Tampa FLA, USA).
In fasting samples, serum total and HDL cholesterol,
and triglycerides (without blanking) were determined
by enzymatic methods on a Vitros 950 (Ortho-Clinical
Diagnostics, Rochester NY, USA). HDL cholesterol
was isolated by precipitation of LDL and VLDL with
dextran sulphate and magnesium chloride (coefficient
of variation (CV) 2.8–3.5%; CVinter 3.3–6.3%). Serum
LDL cholesterol was calculated with the Friedewald
formula, excluding persons with serum triglyceride level
above 5.0 mmol/l. Plasma fibrinogen was measured by
Clauss assay on a STA coagulation analyser (CV 3.6%
for a sample containing 2.8 g/l). Levels of sICAM-1
were measured by capture ELISA (HBT, Uden, The
Netherlands) using a monoclonal antibody to sICAM-1
(HM.2) as capture antibody and a biotin-labelled anti-
ICAM-1 as detection antibody as described earlier [13].
Dietary intake was assessed by a food frequency ques-
tionnaire (FFQ) [12], which was validated using a 3-day
24-h recall method as gold standard. Pearson correla-
tion coefficients between assessment by the FFQ and by
the 24-h recall method were as follows: energy intake
(r=0.76), total fat as percentage of energy (r=0.66),
and saturated fat (r=0.51) (P0.05 for all).
2.4. Assessment of intima-media thickness
High-resolution B-mode ultrasound images (ACU-
SON 128 XP, Mountain View, CA, USA) with a 7.0
MHz linear array transducer were used to measure the
IMT. All scans were performed in the supine position
by the same sonographer, unaware of the clinical status
of the patient. The right and left common carotid,
carotid bulb, and the internal carotid arterial wall
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segments were imaged from a fixed lateral transducer
angle. The common femoral and the superficial femoral
arterial segments were imaged from a fixed anterior
transducer angle. The scans were analysed blindly by an
independent image analyst. The arterial segments were
defined as following: the common carotid arterial wall
segment as 1 cm proximal to the carotid dilatation; the
carotid bulb as the segment between the carotid dila-
tion and the carotid flow divider; the internal carotid
segment as a 1 cm long arterial segment distal to the
flow divider; the common femoral arterial segment as a
1 cm arterial segment proximal to the femoral dilata-
tion; and the superficial femoral artery as the 1 cm
arterial segment distal to the femoral flow divider. The
arterial walls most distant from the transducer were
imaged (far walls).
Scans of each arterial segment were stored in real
time mode on S-VHS videotapes for offline analysis.
From the B-mode images, single video frames were
selected by the analyst for IMT measurements. The
IMT is defined as the distance between the lumen/the
intima and the media/adventitia interfaces. Image anal-
ysis procedures and software are described elsewhere
[14]. An IMT measurement of approximately 10 mm
along the arterial wall was performed manually, by
positioning markers along predefined edges of the near
and far wall double line patterns. The computer pro-
gram subsequently drew lines through the markers.
The carotid and femoral arteries were investigated
bilaterally at various segments. The IMT data are given
as the mean distance between the two interfaces of the
far wall of the left and the right side divided by two,
and the standard deviations. The data on combined
IMT of the carotid and femoral artery were calculated
by adding means of the various segments divided by
three for the carotid artery and two for the femoral
artery (mean mean=Mmean).
2.5. Statistics
Changes in cardiovascular risk factors and dietary
intake during the study when compared to baseline
were analysed with paired student’s t-test. At baseline,
associations between variables and IMT were analysed
with Pearson correlation coefficients or partial correla-
tion coefficients to adjust the confounding variables.
Univariate and multivariate linear regression models
were used to examine the predicting variables of
changes in IMT and sICAM-1. Analysis-of-covariance
techniques (quintiles of change in SFA intake) were
used to examine associations with IMT and sICAM-1,
adjusted for confounding variables and corrected for
multiple testing (indicated in the text and Table 4). The
analyses were performed on an intention-to-treat basis
using the statistical package SPSS 8.0 (SPSS Inc.,
Chicago, USA).
3. Results
3.1. Characteristics of study population
Table 1 shows the characteristics of the study popula-
tion at baseline and changes after 2 years of follow-up.
The mean carotid IMT increased with 0.05 (SD=0.11)
mm (P0.01; n=92) and mean femoral IMT with
0.04 (SD=0.26) mm (NS). The average level of
sICAM-1 decreased with 2 (SD=26) ng/ml (NS). After
2 years, dietary intake of SFA decreased with 1.8%
(SD=2.6) of energy (P0.01; n=80), and there were
non-significant changes in the intake of total fat (−0.8
en%), dietary cholesterol (−11 g/day), dietary fibre
(+0.6 g/day), and fruit (+30 g/day) (Table 2).
3.2. Baseline associations between risk factors and
intima-media thickness
At baseline, Mmean carotid IMT was positively asso-
ciated with age (r=0.49; P0.01), level of sICAM-1
(r=0.29; P0.01; adjusted for age, gender, smoking),
and diastolic and systolic blood pressure (r=0.23 and
0.22, respectively; age adjusted; P0.05). Men had a
higher carotid IMT (0.87 mm; SE=0.02) than women
(0.80 mm; SE=0.02), when adjusted for age (P0.05).
The Mmean femoral IMT was positively associated
with age (r=0.35; P0.01), and men had a higher
Table 1
Characteristics of the study population at baseline and after 2 years
of follow-up a
Baseline (mean 2 years (mean
(SD)) (SD))
6.8 (0.7) −0.4 (0.9)**Serum total cholesterol
(mmol/l)
−0.6 (0.9)**Serum LDL cholesterol 4.6 (0.8)
(mmol/l)
5.7 (1.5) −0.8 (0.9)**Ratio total/HDL cholesterol
Serum triglycerides (mmol/l) 2.1 (1.1) +0.1 (0.8)
0 (16)146 (22)Systolic blood pressure
(mmHg)
Diastolic blood pressure 87 (14) +3 (14)
(mmHg)
Body mass index (kg/m2) 29.7 (3.8) +0.6 (1.2)**
Present smoking (%) 46 −3
0.83 (0.16)Mean carotid IMT (mm) +0.05 (0.11)**
Mean femoral IMT (mm) 0.80 (0.27) +0.04 (0.26)
86 (35)sICAM-1 (ng/ml) −2 (26)
Use of medication (%):
0Lipid-lowering +13
60 +2Antihypertensive
**P0.01, when compared to baseline; LDL= low-density lipo-
protein; HDL=high-density lipoprotein; IMT= intima-media thick-
ness; sICAM=soluble intercellular adhesion molecule.
a Only subjects included with both measurements, men (n=35),
women (n=60) (5510 years).
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Table 2
Changes in dietary intake at 2 years of follow-up a
Changes at 2 yearsBaseline (mean
(SD)) (mean (SD))
Nutrients
9.9 (2.9)Energy (MJ/day) −0.6 (2.3)*
Energy/body weight 116 (34) −7 (26)*
(kJ/kg)
Total fat (% of energy) 37.7 (6.6) −0.8 (6.2)
14.1 (2.8) −1.8 (2.6)**Saturated fat (% of
energy)
Monounsaturated fat 12.5 (2.4) −1.3 (2.3)**
(% of energy)
8.7 (2.6)Polyunsaturated fat (% +2.9 (3.1)**
of energy)
214 (67)Dietary cholesterol −11 (67)
(mg/day)
Dietary fibre (g/day) 26.8 (7.9) +0.6 (7.7)
3.1 (4.0)Alcohol (% of energy) −0.4 (2.4)
Foods
+30 (192)Fruit (g/day) 278 (185)
−5 (24)*51 (25)Total added fat (g/day)
Margarine (g/day) 20 (22) +19 (27)**
Men: (n=31); women: (n=50). *P0.05; **P0.01 when compared
to baseline.
a Only subjects included with both measurements.
3.3. Predictors of changes in intima-media thickness
and sICAM-1
In univariate regression analysis, changes of the
carotid IMT were predicted by baseline carotid IMT,
and changes in the intake of SFA and fruit (Table 3).
Changes of the femoral IMT were predicted by baseline
femoral IMT, age, baseline BMI, and change in the
intake of dietary cholesterol. Changes in levels of
sICAM-1 were predicted by baseline level and BMI.
Changes in dietary intake of energy, total fat, vegeta-
bles, and fatty fish did not predict changes of IMT and
sICAM-1 (data not shown).
In multivariate analysis, progression of femoral IMT
was predicted by baseline femoral IMT, SFA intake
and BMI. Changes in sICAM-1 level were predicted by
baseline level of sICAM-1 and SFA intake, and
changes in SFA intake. Although not significant,
changes in SFA intake were consistently positively as-
sociated with changes in IMT (Table 3).
3.4. Quintiles of change in saturated fat intake and
intima-media thickness
Table 4 shows (changes) in risk factors and dietary
intake for quintiles of change in SFA intake. The intake
of the research margarines was similar among the quin-
tiles (data not shown). An increased SFA intake was
associated with increased progression of the femoral
IMT (P=0.02), and tend to increase the progression of
age-adjusted value (0.88 mm; SE=0.04) than women
(0.75 mm; SE=0.03) (P0.05).
Table 3
Predictors of change in IMT and soluble intercellular adhesion molecule-1 after 2 years, in univariate (UV) and multivariate (MV) regression
analysis (standardized betas)
Dependent variablePredictors
Change in carotid IMT Change in femoral IMT Change in sICAM-1
UV MV UV MV UV MV
−0.21 −0.49**−0.42**−0.22* −0.36**Baseline level −0.48**
0 0.19 −0.28**Age 0.19 0.07 0.14
0.010.070.08 −0.04Gender −0.070.12
0.07 0.07 0.10Baseline smoking 0.20 0.07 0.12
0.060.06Baseline systolic blood pressure −0.11−0.02 −0.07 0.01
Baseline serum LDL cholesterol −0.09−0.06−0.06−0.200.070.04
0.21*−0.25*−0.23* 0.14−0.19−0.17Baseline body mass index
−0.06 0.13 0.14Baseline sICAM-1 –−0.11 –
0.27*Baseline intake saturated fat −0.15 0.19 0.31*0.12 0.07
0.14 0.14Change in systolic blood pressure 0.070.16 0.040.17
−0.14 −0.09Change in serum LDL cholesterol 0.010.080.180.03
0.130.060.070.12Change in body mass index 0.050.06
0.05 −0.16 −0.02 −0.02 – –Change in sICAM-1
0.26* 0.24 0.18 0.21 0.06 0.44**Change in intake of saturated fat
0.01−0.07−0.30*−0.17Change in intake polyunsaturated fat −0.18−0.11
0.09 0.01 0.23* 0.15 −0.07Change in intake of cholesterol −0.19
−0.14−0.23* 0.22Change in intake of fruit 0.130.13−0.02
−0.140−0.05−0.05−0.10Change in intake of alcohol −0.03
*P0.05; **P0.01; IMT= intima-media thickness, LDL= low-density lipoprotein; sICAM-1=soluble intercellular adhesion molecule 1.
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Table 4
Risk factors and changes during the study for quintiles of changes in saturated fat intake after 2 years (mean (SEM))
2 3Quintiles 41 5 P trend a
(n=16) (n=17) (n=16) (n=16)(n=16)
−5.9 (1.4) −2.7 (0.4) −1.7 (0.3)Change in saturated fat intake −0.3 (0.5) +1.6 (0.7)
(en%) (mean (SD))
56.6 (9.0) 51.8 (11.1)Age (years) 58.2 (9.4)55.3 (9.6) 54.1 (9.3)
38 35 4444 31Male sex (%)
6.6 6.6Serum total cholesterol (mmol/l) 7.07.0 6.8
4.4 4.4 4.84.8 4.5Serum LDL cholesterol (mmol/l)
Intake of 0.01Baseline 16.9 (2.4) 14.7 (1.8) 13.8 (1.8) 13.0 (2.0) 12.0 (3.3)
saturated fat
(% of energy)








sICAM-1 82.3 (10.2) 72.8 (7.8) 92.1 (6.5) 82.6 (8.3) 97.3 (10.9)
(ng/ml)
0.02 (0.03) 0.03 (0.03)Changes in Carotid IMT (mm) c 0.09 (0.03)0.03 (0.03) 0.10 (0.03) 0.07




sICAM-1 −19.0 (5.6) −12.7 (4.9) −2.0 (4.8) +5.6 (5.0) +8.6 (5.3) 0.001
(ng/ml) c
Serum LDL −0.5 (0.2) −0.6 (0.2) −0.7 (0.2) −0.9 (0.2) −0.7 (0.2)
cholesterol
(mmol/l) d
Systolic blood −2 (3) −5 (3) −2 (3) +4 (4) +8 (4) 0.05
pressure
(mmHg) e
Body mass +0.2 (0.3) +0.6 (0.3) +0.7 (0.3) +1.3 (0.3) +0.1 (0.3) 0.05(quadr.)
index (kg/m2) f
Dietary intake +2.5 (0.9) +2.7 (0.9) +2.9 (0.8) +2.9 (0.5) +3.6 (0.8)
of PUFA (en%)
Dietary intake −59 (16) −13 (19) +9 (11) −10 (10) +18 (20) 0.01
of cholesterol
(mg/day)
Dietary intake +101 (48) +119 (52) +51 (34) −49 (41) −74 (48) 0.01
of fruit (g/day)
en%=percentage of energy intake; sICAM-1=soluble intercellular adhesion molecule 1; LDL= low-density lipoprotein; PUFA= polyunsatu-
rated fat.
a When corrected for multiple testing the P for trend regarding sICAM-1 is 0.05.
b Adjusted for age, gender, systolic blood pressure.
c Adjusted for baseline level, intake saturated fat, body mass index, age, changes in intake of dietary cholesterol, fruit, polyunsaturated fat.
d Adjusted for lipid-lowering medication, baseline level.
e Adjusted for baseline level, smoking, change in body mass index.
f Adjusted for age, gender.
the carotid IMT (P=0.07) (adjusted for baseline IMT,
BMI, and SFA intake, age, and changes in intake of
fruit, polyunsaturated fat and dietary cholesterol) (Fig.
1). For the carotid (data not shown) and femoral IMT,
the linear trend was similar with additional adjustments
for changes in LDL cholesterol (P=0.01), BMI (P=
0.01), systolic blood pressure (P=0.02), and sICAM-1
(P=0.01).
3.5. Quintiles of change in saturated fat intake and
soluble ICAM-1
Table 4 and Fig. 2 show the changes in sICAM-1
levels per quintile of change in SFA intake. In the
lowest quintile, the sICAM-1 concentration decreased
with 19.0 ng/ml (SEM=5.6) versus an increase of 8.6
ng/ml (SEM=5.3) in the top quintile (P for trend
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Fig. 1. Change in carotid and femoral IMT per quintile of change in
saturated fat intake after 2 years (n=78). Legend. P for trend 0.02
(femoral IMT) and 0.07 (carotid IMT); adjusted for baseline IMT,
body mass index, and saturated fat intake, age, changes in intake of
fruit, dietary cholesterol, polyunsaturated fat.
1 did not alter the linear association between the
changed SFA intake and IMT.
Our findings about an association between the re-
ported SFA intake and sICAM-1 are compatible with
the results of De Caterina and coworkers who found
that fatty acids influence the expression of adhesion
molecules in vitro [5,6]. Plasma levels of sICAM-1 have
been shown to be significantly different between symp-
tomatic and asymptomatic plaques, and risk factor-free
age-matched controls. An increased expression of
ICAM-1 may be involved in the conversion of carotid
plaque to a symptomatic state [15]. Hence, when de-
creasing SFA intake would reduce the expression of
ICAM-1, a component of the inflammatory pathway,
this may not only influence the initiation of formation
of plaques but also the conversion of plaques to a
symptomatic or prothrombotic state.
With respect to other cardiovascular risk factors, we
observed an increased systolic blood pressure and BMI
among the quintiles of changes in SFA intake. At
baseline, the blood pressure was associated with carotid
IMT, and other research showed that an increased BMI
of 1 kg/m2 is associated with excess annual IMT pro-
gression by 0.013 mm/year [16]. However, statistical
adjustments for changes in systolic blood pressure,
BMI, and sICAM-1 did not alter the associations be-
tween changed SFA intake and IMT. This may be
partly due to the small differences in BMI and blood
pressure among the quintiles, and to the small number
of participants in each quintile.
Other limitations of the study are acknowledged. The
present investigation was conducted within the inter-
vention group of a primary prevention project. Unfor-
tunately, the IMT was not assessed in our control
group due to budgetary reasons. Therefore, further
research using randomised controlled trials is necessary
to exclude the possibility of confounding variables and
to confirm causality. For example, the IMT progression
rate may also be predicted by dietary cholesterol [16].
In our study, statistical adjustment for dietary choles-
terol did not alter the association between SFA and
IMT, but dietary intakes of SFA and cholesterol are
usually highly correlated (in our study r=0.42). Since
we found a clear association between SFA and sICAM-
1, we hypothesize that the mechanism by which diet
affects IMT progression includes the expression of
ICAM-1, and SFA intake may be more important in
influencing the progression of IMT than dietary choles-
terol. Another dietary determinant of IMT progression
can be a changed intake of fruit. However, as was the
case with dietary cholesterol, statistical adjustment for
changes in fruit intake did not affect the significance of
the association between changes in SFA intake and
IMT or sICAM-1. Finally, changes in SFA intake may
merely reflect changes in dietary compliance, and hence
perhaps changes in other health behaviours (like physi-
0.001; n=78; adjusted for baseline sICAM-1 level,
BMI and SFA intake, age, and changes in intake of
fruit, polyunsaturated fat, and dietary cholesterol).
4. Discussion
In these moderately hypercholesterolaemic study par-
ticipants, who had two other cardiovascular risk fac-
tors, we showed that decreasing the intake of SFA is
associated with a reduced progression of the femoral
and carotid IMT. The mechanism may involve the
expression of ICAM-1, since we found a clear associa-
tion between changes in SFA intake and sICAM-1.
However, statistical adjustment for changes in sICAM-
Fig. 2. Change in levels of soluble intercellular adhesion molecule-1
(sICAM-1) per quintile of change in saturated fat intake after 2 years
(n=78). Legend. P for trend 0.001; adjusted for baseline sICAM-
1, body mass index, and saturated fat intake, age, and changes in
intake of fruit, dietary cholesterol and polyunsaturated fat.
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cal activity). In the present study this potential source
of bias could not be controlled completely. It should be
noted, however, that adjustments for changes in HDL-,
LDL cholesterol, and BMI that may be determined by
physical activity, did not alter our results.
The association between changes in SFA intake and
femoral IMT remained significant after adjusting the
changes in LDL cholesterol. Although this may seem
surprising, it has been shown previously that the posi-
tive association between SFA intake and risk of devel-
oping CHD (RR=1.11, 95%CI=1.04–1.18) is not
fully mediated by serum lipids [17]. Other studies
showed that the level of sICAM-1 independently pre-
dicts the presence of ischaemic heart disease [7,18].
Further, the ARIC study found a cross-sectional associ-
ation between SFA and carotid IMT, independent of
age, smoking, and established cardiovascular risk fac-
tors [10]. Finally, it has been shown that atherosclerosis
can also regress in persons without a decrease in LDL
cholesterol [19].
The impact of dietary changes on coronary narrow-
ing has been established. Intervention studies, using
quantitative coronary angiographic measures, showed a
25–30% difference in the progression of the extent of
coronary narrowing between the intervention group
(low fat diet) when compared with usual care in pa-
tients with angina pectoris or myocardial infarction
[3,20]. In our study population, which already had a
high PUFA intake at baseline [12], the nutritional
education combined with the free provision of PUFA-
rich margarines decreased average dietary SFA intake
by 1.8% of energy intake after 2 years. The intake of
SFA in industrialized countries exceeds the guidelines
for a healthy diet, which state as goal less than 10% of
energy intake [21]. From a public health perspective, it
is important to stimulate the replacement of products
rich in SFA by products rich in unsaturated fatty acids.
In persons having multiple risk factors the goal for
reducing SFA intake is even lower (7% of energy)
[22]. This is congruent with our findings that emphasise
the need to reduce SFA intake in hypercholesterolaemic
persons with elevated risk of developing CHD.
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